FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1596482015> ?p ?o ?g. }

• W1596482015 abstract "Every drug used to treat cancer (chemotherapeutics, immunological, monoclonal antibodies, nanoparticles, radionuclides) must reach the targeted cells through the tumor environment at adequate concentrations, in order to exert their cell-killing effects. For any of these agents to reach the goal cells, they must overcome a number of impediments created by the tumor microenvironment (TME), beginning with tumor interstitial fluid pressure (TIFP), and a multifactorial increase in composition of the extracellular matrix (ECM). A primary modifier of TME is hypoxia, which increases the production of growth factors, such as vascular endothelial growth factor and platelet-derived growth factor. These growth factors released by both tumor cells and bone marrow recruited myeloid cells form abnormal vasculature characterized by vessels that are tortuous and more permeable. Increased leakiness combined with increased inflammatory byproducts accumulates fluid within the tumor mass (tumor interstitial fluid), ultimately creating an increased pressure (TIFP). Fibroblasts are also up-regulated by the TME, and deposit fibers that further augment the density of the ECM, thus, further worsening the TIFP. Increased TIFP with the ECM are the major obstacles to adequate drug delivery. By decreasing TIFP and ECM density, we can expect an associated rise in drug concentration within the tumor itself. In this overview, we will describe all the methods (drugs, nutraceuticals, and physical methods of treatment) able to lower TIFP and to modify ECM used for increasing drug concentration within the tumor tissue." @default.
• W1596482015 created "2016-06-24" @default.
• W1596482015 creator A5028160515 @default.
• W1596482015 creator A5052488722 @default.
• W1596482015 creator A5075896906 @default.
• W1596482015 date "2015-07-23" @default.
• W1596482015 modified "2023-09-29" @default.
• W1596482015 title "Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid" @default.
• W1596482015 cites W112026335 @default.
• W1596482015 cites W113822656 @default.
• W1596482015 cites W125717340 @default.
• W1596482015 cites W1487831133 @default.
• W1596482015 cites W1495148118 @default.
• W1596482015 cites W1505534997 @default.
• W1596482015 cites W1522090707 @default.
• W1596482015 cites W1525308795 @default.
• W1596482015 cites W1557142436 @default.
• W1596482015 cites W1557991089 @default.
• W1596482015 cites W1576009999 @default.
• W1596482015 cites W1593844282 @default.
• W1596482015 cites W1754823593 @default.
• W1596482015 cites W1810166418 @default.
• W1596482015 cites W1843966557 @default.
• W1596482015 cites W1883506207 @default.
• W1596482015 cites W1896649971 @default.
• W1596482015 cites W1911698430 @default.
• W1596482015 cites W1921630717 @default.
• W1596482015 cites W1931273074 @default.
• W1596482015 cites W1965239268 @default.
• W1596482015 cites W1965498876 @default.
• W1596482015 cites W1969214285 @default.
• W1596482015 cites W1969884573 @default.
• W1596482015 cites W1970240314 @default.
• W1596482015 cites W1970920981 @default.
• W1596482015 cites W1972135632 @default.
• W1596482015 cites W1972428980 @default.
• W1596482015 cites W1975216289 @default.
• W1596482015 cites W1975993453 @default.
• W1596482015 cites W1977527390 @default.
• W1596482015 cites W1979356105 @default.
• W1596482015 cites W1981290668 @default.
• W1596482015 cites W1981486151 @default.
• W1596482015 cites W1982937951 @default.
• W1596482015 cites W1985514828 @default.
• W1596482015 cites W1985957186 @default.
• W1596482015 cites W1987043234 @default.
• W1596482015 cites W1987060944 @default.
• W1596482015 cites W1988265514 @default.
• W1596482015 cites W1989228654 @default.
• W1596482015 cites W1989792740 @default.
• W1596482015 cites W1994850123 @default.
• W1596482015 cites W1996806798 @default.
• W1596482015 cites W1997747808 @default.
• W1596482015 cites W1998883082 @default.
• W1596482015 cites W2002689409 @default.
• W1596482015 cites W2002919033 @default.
• W1596482015 cites W2005371778 @default.
• W1596482015 cites W2006202974 @default.
• W1596482015 cites W2008569669 @default.
• W1596482015 cites W2009953484 @default.
• W1596482015 cites W2010967591 @default.
• W1596482015 cites W2012576981 @default.
• W1596482015 cites W2013239827 @default.
• W1596482015 cites W2013692456 @default.
• W1596482015 cites W2015554909 @default.
• W1596482015 cites W2015872072 @default.
• W1596482015 cites W2016834188 @default.
• W1596482015 cites W2017792770 @default.
• W1596482015 cites W2023756945 @default.
• W1596482015 cites W2024623214 @default.
• W1596482015 cites W2025562467 @default.
• W1596482015 cites W2026103498 @default.
• W1596482015 cites W2028066677 @default.
• W1596482015 cites W2028156849 @default.
• W1596482015 cites W2030716492 @default.
• W1596482015 cites W2032955513 @default.
• W1596482015 cites W2032986552 @default.
• W1596482015 cites W2033784091 @default.
• W1596482015 cites W2039010367 @default.
• W1596482015 cites W2041337540 @default.
• W1596482015 cites W2041600831 @default.
• W1596482015 cites W2044391772 @default.
• W1596482015 cites W2045190338 @default.
• W1596482015 cites W2045732739 @default.
• W1596482015 cites W2045947409 @default.
• W1596482015 cites W2046847797 @default.
• W1596482015 cites W2046981853 @default.
• W1596482015 cites W2047381255 @default.
• W1596482015 cites W2047848650 @default.
• W1596482015 cites W2048095058 @default.
• W1596482015 cites W2048535059 @default.
• W1596482015 cites W2049889525 @default.
• W1596482015 cites W2052862499 @default.
• W1596482015 cites W2054512362 @default.
• W1596482015 cites W2055881439 @default.
• W1596482015 cites W2057281974 @default.
• W1596482015 cites W2060420887 @default.
• W1596482015 cites W2061417923 @default.
• W1596482015 cites W2062244504 @default.
• W1596482015 cites W2063729179 @default.

• next